“NEW YORK – Personalized genomics company MyOme presented data at the recent American Society of Clinical Oncology conference demonstrating its ability to train and validate a cross-ancestry polygenic risk score (caPRS) for breast cancer.”
Read full article here…
We are happy to answer any questions. Contact us at *protected email* with any questions or to keep apprised of any development, provide your name and email information.
OFFICE: Menlo Park, California
LAB: San Carlos, California